Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

Validated Phenotypic Approach to Neuropsychiatric Drug Discovery

March 1, 2019
Read More
PUBLICATION

Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain

February 1, 2019
Read More
PUBLICATION

Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E

October 1, 2018
Read More
PUBLICATION

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease

August 1, 2018
Read More
PUBLICATION

Synergistic antileukemic therapies in NOTCH1-induced T-ALL.

October 12, 2017
Read More
PUBLICATION

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

October 11, 2017
Read More
PUBLICATION

High-throughput validation of ceRNA regulatory networks

October 10, 2017
Read More
PUBLICATION

Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity

August 28, 2017
Read More
PUBLICATION

Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer

May 1, 2017
Read More